Free Access
| Issue |
Med Sci (Paris)
Volume 31, Number 10, Octobre 2015
|
|
|---|---|---|
| Page(s) | 832 - 834 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/20153110007 | |
| Published online | 19 October 2015 | |
- Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012 ; 30 : 531–564. [CrossRef] [PubMed] [Google Scholar]
- Stockis J, Fink W, Francois V, et al. Comparison of stable human Treg and Th clones by transcriptional profiling. Eur J Immunol 2009 ; 39 : 869–882. [CrossRef] [PubMed] [Google Scholar]
- Travis MA, Sheppard D. TGF-beta activation and function in immunity. Annu Rev Immunol 2014 ; 32 : 51–82. [CrossRef] [PubMed] [Google Scholar]
- Stockis J, Colau D, Coulie PG, Lucas S. Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur J Immunol 2009 ; 39 : 3315–3322. [CrossRef] [PubMed] [Google Scholar]
- Tran DQ, Andersson J, Wang R, et al. GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 2009 ; 106 : 13445–13450. [CrossRef] [Google Scholar]
- Cuende J, Liénart S, Dedobbeleer O, et al. Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo. Sci Transl Med 2015; 7 : 284ra56. [CrossRef] [PubMed] [Google Scholar]
- Piccirillo CA, Letterio JJ, Thornton AM, et al. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 2002 ; 196 : 237–246. [CrossRef] [PubMed] [Google Scholar]
- Marie JC, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 2006 ; 25 : 441–454. [CrossRef] [PubMed] [Google Scholar]
- Li MO, Wan YY, Flavell RA. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 2007 ; 26 : 579–591. [CrossRef] [PubMed] [Google Scholar]
- Simpson TR, Li F, Montalvo-Ortiz W, et al. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma. J Exp Med 2013 ; 210 : 1695–1710. [CrossRef] [PubMed] [Google Scholar]
- Siri A, de Boysson H, Boursier G. Actualité sur les lymphocytes T régulateurs CD4+. Med Sci (Paris) 2012 ; 28 : 646–651. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.